Stocks
Haemonetics Corporation (HAE) EV/EBITDA US GAAP (year values) |
|||||||||
| FY2022 | FY2023 | FY2024 | FY2025 | FY2026 | LTM ? | CAGR 5 years ? | |||
| EV/EBITDA | ? | 19.6 | 18.6 | 2.13 | 2.58 | 3.13 | 2.90 | ||
| Changes by years, y/y, % | -42% | -5% | -89% | +21% | +22% | -37.8% | |||
Haemonetics Corporation. EV/EBITDA
Haemonetics Corporation. EV/EBITDA, changes, %
Haemonetics Corporation (HAE) EV/EBITDA US GAAP (quarter values) |
||||||||
| FY2025Q4 | FY2026Q1 | FY2026Q2 | FY2026Q3 | FY2026Q4 | LTM ? | |||
| EV/EBITDA | ? | 11.8 | 2.61 | 2.61 | 2.42 | 3.49 | 2.90 | |
| Changes by years, y/y, % | +448% | -12% | -10% | -11% | -70% | |||
| Changes by quarters, q/q, % | +333% | -78% | +0% | -7% | +44% | |||
